Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Jan;108(1):1–4. doi: 10.1289/ehp.001081

Cancer mortality and environmental exposure to DDE in the United States.

P Cocco 1, N Kazerouni 1, S H Zahm 1
PMCID: PMC1637846  PMID: 10620518

Abstract

To explore the role of DDE, the major and most persistent DDT derivative, in cancer etiology, we examined the association of the 1968 adipose DDE levels of population samples from 22 U.S. states with age-adjusted mortality rates between 1975 and 1994 for multiple myeloma; non-Hodgkin lymphoma (NHL); and cancer of the breast, corpus uteri, liver, and pancreas. Separate analyses were conducted by gender and race. Covariates in the regression models included average per-capita income, percent metropolitan residents, and the population density. Liver cancer mortality increased significantly with adipose DDE levels in both sexes among whites, but not among African Americans. No association was observed for pancreatic cancer and multiple myeloma. Breast cancer mortality was inversely correlated with adipose DDE levels among both white and African American women. Significant inverse correlations were also observed for uterine cancer among white women, whereas no association was observed for African Americans and for NHL among whites (men and women) and African American women. The results for pancreatic cancer, multiple myeloma, NHL, breast cancer, and uterine cancer did not support the hypothesis of an association with past adipose levels of the DDT derivative DDE. The multivariate analysis confirmed most findings. The association between liver cancer and DDE observed among whites, particularly in view of the occurrence of hepatic neoplasms in laboratory animals exposed to DDT, warrants further investigation.

Full text

PDF
1

Images in this article

2Figure 1
on p.2
2Figure 2
on p.2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baris D., Zahm S. H., Cantor K. P., Blair A. Agricultural use of DDT and risk of non-Hodgkin's lymphoma: pooled analysis of three case-control studies in the United States. Occup Environ Med. 1998 Aug;55(8):522–527. doi: 10.1136/oem.55.8.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown P. Race, class, and environmental health: a review and systematization of the literature. Environ Res. 1995 Apr;69(1):15–30. doi: 10.1006/enrs.1995.1021. [DOI] [PubMed] [Google Scholar]
  3. Cocco P., Blair A., Congia P., Saba G., Flore C., Ecca M. R., Palmas C. Proportional mortality of dichloro-diphenyl-trichloroethane (DDT) workers: a preliminary report. Arch Environ Health. 1997 Jul-Aug;52(4):299–303. doi: 10.1080/00039899709602202. [DOI] [PubMed] [Google Scholar]
  4. Dorgan J. F., Brock J. W., Rothman N., Needham L. L., Miller R., Stephenson H. E., Jr, Schussler N., Taylor P. R. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control. 1999 Feb;10(1):1–11. doi: 10.1023/a:1008824131727. [DOI] [PubMed] [Google Scholar]
  5. Falck F., Jr, Ricci A., Jr, Wolff M. S., Godbold J., Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health. 1992 Mar-Apr;47(2):143–146. [PubMed] [Google Scholar]
  6. Flodin U., Fredriksson M., Persson B., Axelson O. Chronic lymphatic leukaemia and engine exhausts, fresh wood, and DDT: a case-referent study. Br J Ind Med. 1988 Jan;45(1):33–38. doi: 10.1136/oem.45.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garabrant D. H., Held J., Langholz B., Peters J. M., Mack T. M. DDT and related compounds and risk of pancreatic cancer. J Natl Cancer Inst. 1992 May 20;84(10):764–771. doi: 10.1093/jnci/84.10.764. [DOI] [PubMed] [Google Scholar]
  8. Hoffman W. Organochlorine compounds: Risk of non-Hodgkin's lymphoma and breast cancer? Arch Environ Health. 1996 May-Jun;51(3):189–192. doi: 10.1080/00039896.1996.9936015. [DOI] [PubMed] [Google Scholar]
  9. Hunter D. J., Hankinson S. E., Laden F., Colditz G. A., Manson J. E., Willett W. C., Speizer F. E., Wolff M. S. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med. 1997 Oct 30;337(18):1253–1258. doi: 10.1056/NEJM199710303371801. [DOI] [PubMed] [Google Scholar]
  10. Høyer A. P., Grandjean P., Jørgensen T., Brock J. W., Hartvig H. B. Organochlorine exposure and risk of breast cancer. Lancet. 1998 Dec 5;352(9143):1816–1820. doi: 10.1016/S0140-6736(98)04504-8. [DOI] [PubMed] [Google Scholar]
  11. Kelce W. R., Stone C. R., Laws S. C., Gray L. E., Kemppainen J. A., Wilson E. M. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature. 1995 Jun 15;375(6532):581–585. doi: 10.1038/375581a0. [DOI] [PubMed] [Google Scholar]
  12. Krieger N., Wolff M. S., Hiatt R. A., Rivera M., Vogelman J., Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst. 1994 Apr 20;86(8):589–599. doi: 10.1093/jnci/86.8.589. [DOI] [PubMed] [Google Scholar]
  13. López-Carrillo L., Blair A., López-Cervantes M., Cebrián M., Rueda C., Reyes R., Mohar A., Bravo J. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res. 1997 Sep 1;57(17):3728–3732. [PubMed] [Google Scholar]
  14. Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Public Health. 1982 Dec;72(12):1336–1344. doi: 10.2105/ajph.72.12.1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Saxena S. P., Khare C., Farooq A., Murugesan K., Buckshee K., Chandra J. DDT and its metabolites in leiomyomatous and normal human uterine tissue. Arch Toxicol. 1987 Apr;59(6):453–455. doi: 10.1007/BF00316214. [DOI] [PubMed] [Google Scholar]
  16. Sturgeon S. R., Brock J. W., Potischman N., Needham L. L., Rothman N., Brinton L. A., Hoover R. N. Serum concentrations of organochlorine compounds and endometrial cancer risk (United States). Cancer Causes Control. 1998 Aug;9(4):417–424. doi: 10.1023/a:1008823802393. [DOI] [PubMed] [Google Scholar]
  17. Unger M., Kiaer H., Blichert-Toft M., Olsen J., Clausen J. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res. 1984 Jun;34(1):24–28. doi: 10.1016/0013-9351(84)90072-0. [DOI] [PubMed] [Google Scholar]
  18. Wassermann M., Nogueira D. P., Tomatis L., Mirra A. P., Shibata H., Arie G., Cucos S., Wassermann D. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol. 1976 Apr;15(4):478–484. doi: 10.1007/BF01685076. [DOI] [PubMed] [Google Scholar]
  19. Wolff M. S., Toniolo P. G., Lee E. W., Rivera M., Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993 Apr 21;85(8):648–652. doi: 10.1093/jnci/85.8.648. [DOI] [PubMed] [Google Scholar]
  20. Woodruff T., Wolff M. S., Davis D. L., Hayward D. Organochlorine exposure estimation in the study of cancer etiology. Environ Res. 1994 Apr;65(1):132–144. doi: 10.1006/enrs.1994.1026. [DOI] [PubMed] [Google Scholar]
  21. Woods J. S., Polissar L., Severson R. K., Heuser L. S., Kulander B. G. Soft tissue sarcoma and non-Hodgkin's lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington. J Natl Cancer Inst. 1987 May;78(5):899–910. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES